SEC Form 4Coverage since May 22, 2026
$DNA insider trading
Over the last 12 months, Ginkgo Bioworks Holdings insiders reported no purchases and 2 sales totaling $9K across SEC Form 4 filings.
- Bought · 12m
- — 0 events
- Sold · 12m
- $9K 2 events
- Events · 12m
- 2 Form 4 filings, grouped
- Insiders · 12m
- 1 distinct reporters
- 10b5-1 share
- 0% pre-arranged plans
Side
Price · $DNA · 12Mvia TradingView
Top insiders · 12m
Coen Steven P.See remarks2× · $9K
All insider trades
2 events
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Jul 17, 2026 | Coen Steven P.See remarks · O | ▼ Sale | 752 | $7.9 | $6K | -1.4% | — |
| May 22, 2026 | Coen Steven P.See remarks · O | ▼ Sale | 307 | $8.33 | $3K | -0.6% | — |
About Form 4
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $DNA feed.